Fundraising Fox

Feldan Therapeutics

2 known investors

feldan.com ↗

Feldan Therapeutics is a clinical-stage biotech company developing treatments based on intracellular delivery of therapeutics. It has created the Feldan Shuttle, a peptide-based technology for delivering therapeutics inside cells to reach targets that are otherwise inaccessible.

BiotechDeep Tech

Investors · 2

Genesys CapitalToronto · $730K – $3.6M
Linearis VenturesQuebec City

In the news

FELDAN THERAPEUTICS - SHUTTLE TECHNOLOGY DRIVES COLLABORATIVE INITIATIVE SUPPORTED BY GRANT FUNDING THROUGH MÉDICAMENT QUÉBEC TO ADVANCE mRNA THERAPEUTICS - BIOTECanadabiotech.ca · Sep 2025Feldan Therapeutics: A Breakthrough in Intracellular Delivery from Quebec - MedicalExpo e-Magazineemag.medicalexpo.com · May 2025Feldan Therapeutics Receives Investment from Zynext Venturesfinsmes.com · Apr 2025FELDAN THERAPEUTICS ACCELERATES GROWTH WITH STRATEGIC INVESTMENT FROM LINEARIS VENTURESfinance.yahoo.com · Feb 2025IN PURSUIT OF INNOVATION: FELDAN THERAPEUTICS SECURES US$21 MILLION IN FINANCING - ROBICrobic.ca · Sep 2024FELDAN THERAPEUTICS COMPLETES A US$ 21 MILLION SERIES B FINANCING CO-LED BY GENESYS CAPITAL AND FONDS DE SOLIDARITÉ FTQfinance.yahoo.com · Sep 2024

Frequently asked questions

What does Feldan Therapeutics do?
Feldan Therapeutics is a clinical-stage biotech company developing treatments based on intracellular delivery of therapeutics. It has created the Feldan Shuttle, a peptide-based technology for delivering therapeutics inside cells to reach targets that are otherwise inaccessible.
Who are Feldan Therapeutics's investors?
Feldan Therapeutics's investors include Genesys Capital, Linearis Ventures.